11 – 20 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Global transcriptional changes following statin treatment in breast cancer.
(
- Contribution to journal › Article
-
Mark
Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.
(
- Contribution to journal › Article
-
Mark
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
(
- Contribution to journal › Article
-
Mark
An international study to increase concordance in Ki67 scoring.
(
- Contribution to journal › Article
-
Mark
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
(
- Contribution to journal › Article
-
Mark
Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013
(
- Contribution to journal › Published meeting abstract
-
Mark
Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.
(
- Contribution to journal › Article
- 2014
-
Mark
A novel model for Ki67 assessment in breast cancer.
(
- Contribution to journal › Article
-
Mark
The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer.
(
- Contribution to journal › Article